Jane Street Group, LLC Blueprint Medicines Corp Transaction History
Jane Street Group, LLC
- $88.2 Billion
- Q2 2024
A detailed history of Jane Street Group, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 142,357 shares of BPMC stock, worth $14.4 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
142,357
Previous 167,706
15.12%
Holding current value
$14.4 Million
Previous $15.9 Million
3.55%
% of portfolio
0.02%
Previous 0.02%
Shares
25 transactions
Others Institutions Holding BPMC
# of Institutions
342Shares Held
62.1MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$670 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$659 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$592 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$326 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$248 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.02B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...